Conditions: Solid Tumors High Grade Gliomas Lung Cancer Head and Neck Cancer Sarcoma Renal Cell Carcinoma Breast Cancer
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 70
Healthy volunteers: no

Brief summary:
Study aimed to assess the reproducibility of PET imaging using AH111585 (18F) Injection. Subjects are evaluable if they undergo 2 administrations of AH111585 (18F) Injection (3 to 8 days apart) and the corresponding PET acquisitions, and tumors demonstrate detectable levels of 18F uptake on PET.

Detailed description:

Arms:
arm 1: Fluciclatide Injection

Interventions: intervention 1: Fluciclatide Injection
Intervention descriptions: intervention 1: Fluciclatide Injection (AH111585 (18F) Injection)

Protocol document: